Patents by Inventor Flavia IZZO

Flavia IZZO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 1-H-pyrrolo[2,3-c]pyridine compounds
    Patent number: 12616682
    Abstract: Compounds having the structure of Formula (I): and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, and A are as defined in the specification; pharmaceutical compositions comprising such compounds and salts; use of such compounds and salts to treat or prevent Menin-mediated conditions; kits comprising such compounds and salts; and methods for manufacturing such compounds and salts.
    Type: Grant
    Filed: January 27, 2025
    Date of Patent: May 5, 2026
    Assignee: ACERTA PHARMA B.V.
    Inventors: Stephen Atkinson, Gerjan De Bruin, Flavia Izzo, Chimed Jansen, Olaf Kinzel, Martin Packer, Saskia Verkaik, Robin Voets
  • 1-H-PYRROLO[2,3-c]PYRIDINE COMPOUNDS
    Publication number: 20250360112
    Abstract: Compounds having the structure of Formula (I): and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, and A are as defined in the specification; pharmaceutical compositions comprising such compounds and salts; use of such compounds and salts to treat or prevent Menin-mediated conditions; kits comprising such compounds and salts; and methods for manufacturing such compounds and salts.
    Type: Application
    Filed: January 27, 2025
    Publication date: November 27, 2025
    Inventors: Stephen ATKINSON, Gerjan DE BRUIN, Flavia IZZO, Chimed JANSEN, Olaf KINZEL, Martin PACKER, Saskia VERKAIK, Robin VOETS
  • 1-H-PYRROLO[2,3-c]PYRIDINE COMPOUNDS
    Publication number: 20240335431
    Abstract: Compounds having the structure of Formula (I): and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, and A are as defined in the specification; pharmaceutical compositions comprising such compounds and salts; use of such compounds and salts to treat or prevent Menin-mediated conditions; kits comprising such compounds and salts; and methods for manufacturing such compounds and salts.
    Type: Application
    Filed: March 22, 2024
    Publication date: October 10, 2024
    Inventors: Stephen ATKINSON, Gerjan DE BRUIN, Flavia IZZO, Chimed JANSEN, Olaf KINZEL, Martin PACKER, Saskia VERKAIK, Robin VOETS